Corcept Therapeutics, Inc. (CORT) Reports Q3 EPS Loss of $0.08

November 7, 2011 9:01 AM

Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).

No results found